Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ste12 transcription factor is a central regulator of fungal development and reproduction, primarily characterized in Saccharomyces cerevisiae but conserved across many fungal pathogens (UniProt: P13586). It serves as the terminal effector of the pheromone-responsive Mitogen-Activated Protein Kinase (MAPK) signaling pathway, where its activation leads to the expression of genes essential for mating and filamentous growth. In pathogenic species such as Candida albicans (where the homolog is known as Cph1) and Cryptococcus neoformans, Ste12-like proteins are critical for the yeast-to-hyphae transition, a morphological shift directly linked to host tissue invasion and overall virulence (PubMed: 11110609). While no FDA-approved drugs currently target Ste12, it is a subject of research as a potential anti-virulence target; inhibiting its function could attenuate the pathogenicity of fungal infections without the selective pressure of traditional fungicides. The protein's DNA-binding capacity is mediated by a TEA/ATTS domain, which is evolutionarily related to the human TEAD family of transcription factors (PubMed: 22510271). Consequently, therapeutic development requires high molecular specificity to ensure that antifungal agents do not interfere with human developmental pathways regulated by TEAD proteins. Current efforts in drug discovery focus on identifying small molecules that disrupt Ste12-DNA binding or its interaction with co-regulators like Tec1.
Potential therapeutic mechanisms involve the inhibition of the conserved TEA DNA-binding domain to prevent association with pheromone response elements (PREs) or the blockade of phosphorylation by upstream MAP kinases such as Fus3 and Kss1 (UniProt: P13586).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ste12 transcription factor (Ste12) (Ste12).